BioSpace News Archive

Business

Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress

Total revenue was $83.8 million in the third quarter of 2017, compared with $82.3 million in the third quarter of 2016.

November 8, 2017
·
24 min read
Business

Aerie Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

As of September 30, 2017, Aerie had cash, cash equivalents and investments of $282.2 million.

November 8, 2017
·
14 min read
Business

Nortech Systems Reports Third Quarter Results

Nortech Systems today reported net sales of $28.3 million for the third quarter ended September 30, compared with net sales of $29.7 million for the third quarter of 2016.

November 8, 2017
·
5 min read
Business

Profound Medical Corp. Announces Third Quarter 2017 Financial Results

For the quarter ended September 30, 2017, the Company recorded revenues of $1,465,412, with $1,452,773 from the sale of products and $12,639 from installation and training services.

November 8, 2017
·
12 min read
Business

Alder BioPharmaceuticals Announces Third Quarter 2017 Financial and Operating Results

Research and development expenses for the quarter ended September 30, 2017 totaled $52.2 million, compared to $29.5 million for the same period in 2016.

November 8, 2017
·
9 min read
Business

REVA Medical Reports Third Quarter 2017 Financial Results

The Company initiated commercial sales of the Fantom bioresorbable scaffold and reported total billings for shipped product of $105,000 with $17,000 of revenue recognized for the third quarter of 2017 compared to no billings or revenue for the same period in 2016.

November 8, 2017
·
10 min read
Bio NC

RedHill Biopharma Announces Proposed Public Offering of Its American Depositary Shares

The Company intends to use the proceeds from the offering to fund clinical development programs, for potential acquisitions, to support commercial operations and for general corporate purposes.

November 8, 2017
·
7 min read
Business

TESARO Announces Third-Quarter 2017 Operating Results

TESARO reported total revenue of $142.8 million for the third quarter of 2017, compared to $17.0 million for the third quarter of 2016.

November 8, 2017
·
16 min read
Business

ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights

Pro forma cash, cash equivalents, investments and remaining upfront commitments totaled $154.8 million at September 30, 2017.

November 8, 2017
·
9 min read
Business

Amedisys Reports Third Quarter 2017 Financial Results

Net service revenue increased $18.6 million to $380.2 million compared to $361.6 million in 2016.

November 8, 2017
·
23 min read